Navigation Links
NYSE Amex LLC Accepts Plan of Compliance of The Quantum Group, Inc.
Date:6/3/2009

WELLINGTON, Fla., June 3 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP) (the "Company"), announced today that on May 28, 2009, the NYSE Amex LLC (the "Exchange") accepted the Company plan of compliance with respect to its previously disclosed listing deficiency as set forth in Section 1003(a)(iv) of the Exchange Company Guide. The Company was afforded the opportunity to submit a plan of compliance to the Exchange and on April 15, 2009 presented its plan to the Exchange, with subsequent submissions to the plan. On May 28, 2009, the Exchange notified the Company that it accepted the Company plan of compliance and granted the Company an extension until September 17, 2009, to regain compliance with the continued listing standards. The Company will be required to provide the Exchange staff with updates in conjunction with the initiatives of the plan of compliance as appropriate or upon the Exchange's request and the Exchange staff will review the Company periodically for compliance with the plan of compliance during the extension period. Failure to make progress consistent with the plan of compliance or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the Exchange.

About The Quantum Group, Inc.

The Quantum Group is an innovation-driven Healthcare Services Organization (HSO) that provides business process solutions, service chain management, strategic consulting and leading edge technology to the healthcare industry.

Quantum has developed and deployed PWeR(TM) (www.myPWeR.com), a cutting-edge, patent-pending healthcare technology system that has been designed to bridge the gaps of communication and exchange of patient information throughout the healthcare industry. To date eighteen provisional and one utility patent application have been filed in support of PWeR. The system can integrate all of the functions a physician/provider, hospital, clinic and related professionals utilize in one patient-centric, web-based platform and falls well within the economic incentives offered by the new $19 billion Stimulus Package for healthcare information technology. We believe we are positioned to be a catalyst for change as we take aim at the $700 billion inefficiency gap in the United States healthcare industry.

For more information, please visit http://www.QuantumMD.com.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the Company's 10-K, 10-Q, 8-K and other filings with the SEC (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

                     FOR MORE INFORMATION, PLEASE CONTACT:
                               RedChip Companies
                        Dave Gentry:  407.644.4256 x104
                               dave@redchip.com
                                      or
                             PR Financial Marketing
                           Jim Blackman: 713.256.0369
                              jim@prfmonline.com
                                      or
                            The Quantum Group, Inc.
                        Danielle Amodio:  561.798.9800
                             DAmodio@QuantumMD.com


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. United States Patent and Trademark Office Accepts CoolTouch's Re-examination Request for Cynosure '873 Patent
2. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
3. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value
4. FDA Accepts Nuvos Resubmission For Pennsaid(R)
5. ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
6. Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute
7. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
8. FDA accepts Labopharms response for once-daily tramadol as complete Class 2 response
9. FDA Accepts Gentas NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia
10. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
11. AMEX Accepts Lorus Plan to Meet AMEXs Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... Michael Vick announced ... transforming the quarterback position. The former overall number one pick in the 2001 NFL ... career. He holds the record for the most career rushing yards by a quarterback ...
(Date:4/24/2017)... ... 2017 , ... As part of the nationwide Days of Remembrance effort led ... Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced ... trip to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection of ... is proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder ... of the Board and launched a national search to find a visionary new leader to ...
(Date:4/24/2017)... ... ... Veteran Theresa James awoke to the sound of her newly ex-husband breaking into ... depicts every parent’s worst nightmare, when her three children were violently taken from her. ... my divorce,” James said. “After the death of my children, I continued to journal. ...
(Date:4/24/2017)... ... April 24, 2017 , ... The ... public support to bring their novel lifesaving device for the everyday use of ... medical-grade sensors, specially designed to read a child’s vital signs, and detect unusual ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Cardiology devices segment is anticipated to ... The Cardiology Devices segment is likely to create absolute ... in 2018 over 2017. By the end of 2027, Cardiology ... to US$ 700 Mn, expanding at a CAGR of 18.4% ... Asia Pacific reprocessed medical devices market ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
Breaking Medicine Technology: